Molecular Imaging

Molecular Imaging

Molecular Imaging

January 13, 2012 – The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary recall of CardioGen-82 last July by the manufacturer,...

Royal Philips Electronics announced 510(k) clearance from the Food and Drug Administration (FDA) for the company’s first commercially available whole body positron emission tomography/magnetic resonance (PET/MR) imaging system, the Ingenuity TF PE...

The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals to stop using CardioGen-82 for cardiac positron emission tomography (PET) scans. The manufacturer, Bracco Diagnostics Inc., has decided to voluntarily recall CardioGe...

June 10, 2011 – The U.S. Food and Drug Administration (FDA) granted Siemens Healthcare 510(k) clearance for the Biograph mMR, the first system worldwide to enable simultaneous whole-body acquisition of data from magnetic resonance (MR) and positron e...
February 22, 2012 — Cardiologists are expecting to use fewer imaging modalities per patient case in the future, according to a new report released by market...
February 16, 2012 — Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) recently cleared the features associated with the new...
February 13, 2012 — In two new studies featured in the February issue of The Journal of Nuclear Medicine, researchers revealed how molecular imaging can be...
January 30, 2012 — Positron Corp., a molecular imaging healthcare company specializing in the field of nuclear cardiology, announced Jan. 23 that its wholly...
Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) recently cleared the features associated with the new
GE Healthcare announced the Brivo NM615 was cleared by the U.S. Food and Drug Administration (FDA) in January 2012.  An advanced...
During RSNA 2011, TeraRecon Inc. demonstrated a suite of innovative tools for its iNtuition solution to support new applications for...
Mirada Medical has released a software magnetic resonance/positron emission tomography (MR/PET) technology compatible with any site’s data...

Articles

The new imaging modality of positron emission tomography (PET)/magnetic resonance imaging (MRI) was introduced in the U.S. market last summer. The Siemens...
Several positron emission tomography (PET) imaging agents are being developed to visualize Alzheimer’s disease in the living brain to accurately diagnose...
September 1, 2011 – As with all chronic illnesses, it is everyone's dream to be able to diagnose Alzheimer's disease in the early stages. Naturally, the aim is...
The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals to stop using CardioGen-82 for cardiac positron emission tomography (PET)...

Video Center

Eastman Kodak was slain by its own sword. But it was pride that drove the blade, fueled by the...
6 days 6 hours ago
Murphy's Law... One day before this year's Super Bowl, my 10-year-old TV gave up the ghost. Forced...
1 week 2 days ago
We have entered a time in this country when more powerful is not necessarily better, when we can do...
3 weeks 4 hours ago
As modern multi-detector computed tomography (MDCT) becomes a primary imaging modality across all specialties, there has been increased focus on lowering the radiation dose required to create...
The presentation is designed to introduce the audience to the new wide bore 3T MRI systems recently brought to market. The new systems offer several advantages including improved field homogeneity,...
Performance of cardiac CT (CCTA) in the emergency department (ED) is rapidly becoming the standard-of-care in patients presenting to the ED with chest pain that are at low to intermediate risk for...